PDT Partners’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-111,256
| Closed | -$3.01M | – | 856 |
|
|
2024
Q2 | $3.01M | Buy |
111,256
+219
| +0.2% | +$4.55K | 0.28% | 109 |
|
|
2024
Q1 | $2.03M | Sell |
111,037
-34,270
| -24% | -$544K | 0.19% | 188 |
|
|
2023
Q4 | $1.78M | Buy |
+145,307
| New | +$1.36M | 0.2% | 174 |
|
|
2023
Q2 | – | Sell |
-39,926
| Closed | -$1.56M | – | 677 |
|
|
2023
Q1 | $1.56M | Buy |
39,926
+9
| +0% | +$440 | 0.21% | 171 |
|
|
2022
Q4 | $2.11M | Buy |
39,917
+32,131
| +413% | +$1.56M | 0.34% | 75 |
|
|
2022
Q3 | $350K | Buy |
+7,786
| New | +$335K | 0.05% | 537 |
|
|
2022
Q2 | – | Sell |
-26,455
| Closed | -$1.09M | – | 1195 |
|
|
2022
Q1 | $1.09M | Sell |
26,455
-10,430
| -28% | -$367K | 0.09% | 341 |
|
|
2021
Q4 | $1.57M | Sell |
36,885
-16,820
| -31% | -$841K | 0.12% | 271 |
|
|
2021
Q3 | $2.96M | Buy |
53,705
+3,887
| +8% | +$203K | 0.21% | 202 |
|
|
2021
Q2 | $2.38M | Buy |
49,818
+40,832
| +454% | +$2.08M | 0.16% | 248 |
|
|
2021
Q1 | $455K | Buy |
8,986
+681
| +8% | +$37.9K | 0.03% | 530 |
|
|
2020
Q4 | $523K | Buy |
+8,305
| New | +$515K | 0.04% | 444 |
|
|
2020
Q2 | – | Sell |
-13,711
| Closed | -$432K | – | 853 |
|
|
2020
Q1 | $432K | Buy |
+13,711
| New | +$549K | 0.03% | 411 |
|
Other funds holding SILK
PDT Partners's SILK Position: Q3 2024 in Review
PDT Partners sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 111,256 shares — an estimated $3.01M sold.
PDT Partners first reported a position in SILK in Q1 2020 and held it in 13 quarters. The position peaked at $3.01M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- PDT Partners reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- PDT Partners sold 111,256 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $3.01M.
- PDT Partners first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
- PDT Partners's Silk Road Medical, Inc. Common Stock position peaked at $3.01M in Q2 2024.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.